GE Healthcare

March 5, 2024

GE HealthCare & Vanderbilt publish data on AI models predicting patient response to immunotherapy

The results from a research partnership between GE HealthCare and Vanderbilt University Medical Center utilizing artificial intelligence to enable safer and more precise cancer immunotherapies show that the models they developed predict patient responses with 70% to 80% accuracy.

By Tom Wilemon
November 12, 2020

Spalluto graduates from Radiology leadership program

Lucy Spalluto, MD, MPH, associate professor of Radiology and Radiological Sciences and director of Women in Radiology (WIR), recently graduated from the Leading, Empowering and Disrupting (LEAD) Program, a joint initiative of the Society of Chairs of Academic Radiology Departments’ (SCARD) and GE Healthcare.

By Krystyna Barnard
Charles Manning, PhD, and colleagues are working to improve the effectiveness of immunotherapies earlier in treatment.
November 7, 2019

Project seeks new way to assess immunotherapy effectiveness

GE Healthcare has awarded researchers in the Vanderbilt University Institute of Imaging Science $2.5 million in funding to develop PET tracer that will determine the effectiveness of immunotherapy in patients early in their treatment course.

By Krystyna Barnard
January 7, 2019

GE Healthcare, Vanderbilt University Medical Center partner for safer, more precise immunotherapy cancer treatment

GE Healthcare and Vanderbilt University Medical Center (VUMC) today announced a five-year partnership to enable safer and more precise cancer immunotherapies.

By VUMC News and Communications